DDR1 and neoplasm: In our study, DDR1 expression was detected in 66 of 94 (70.2%) patients with PCa and was significantly correlated with high Gleason score (P < 0.001), advanced pathological tumour stage (P = 0.024), distal metastases (P < 0.001) and shorter overall survival (P = 0.028).